JB Pharma records revenue growth of 36% to INR 809 crores in Q2 FY23
Operating EBITDA* grew by 44% to INR 202 crores Mumbai (Maharashtra), [India]: JB Pharma, one of the fastest growing pharmaceutical companies in India continued on its strong growth momentum, announced its financial results for the second quarter ended 30th September 2022, registering YoY growth of 36% in Q2 FY23 and 33% in H1 FY23. The…